A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in the Treatment of Participants With Ischemic Stroke

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNeuravi Limited

About this trial

The purpose of this study is to collect medical information to monitor the ongoing safety of the J\&J MedTech devices and to understand how well they work when routinely used to treat participants with acute ischemic stroke (a condition caused by a blocked blood vessel in the brain).

Eligibility criteria

Qualifiers

Participant is 18 years of age or older at the time of consent

Informed Consent has been provided by the participant or the participants' legally authorized representative (LAR)

Participants with angiographic confirmation of acute ischemic stroke

A clinical decision has been made to treat the participant with an eligible Johnson & Johnson MedTech neuro-thrombectomy device independently and prior to enrollment in the study

Disqualifiers

Known pregnancy, as evidenced by positive pregnancy test for women of childbearing potential or breast feeding

Current involvement in an investigational (drug, device, etcetera) clinical study that may confound study endpoints. Sponsor approval is required prior to enrollment

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

5,000 Participants
are grouped into 1 trial group

Sponsors and collaborators